The purpose of this study is to evaluate the safety and immunogenicity of a recombinant envelope protein of human immunodeficiency virus-1, gp120 (CHO), combined with an adjuvant, MTP-PE/MF59 in healthy volunteers. It will compare three antigen dose levels, and will also determine the effect of MTP-PE on the cellular and humoral immune response, and this will provide additional information to that currently available regarding the safety of the adjuvant prepartaion.
Showing the most recent 10 out of 515 publications